Max Robotics — Global Service Robot Directory + US Certification

About

Neil S. Horowitz is a leading gynecologic oncologist whose research focuses on advancing minimally invasive surgical approaches for gynecologic cancers, particularly endometrial and ovarian malignancies. His work has significantly shaped clinical practice, most notably through his landmark study on same-day discharge after laparoscopic hysterectomy for endometrial cancer, which has garnered 57 citations and helped establish the safety and feasibility of outpatient surgical management. More recently, Dr. Horowitz has tackled the controversial and high-stakes area of laparoscopic cytoreduction following neoadjuvant chemotherapy in high-grade epithelial ovarian cancer. His 2024 paper, already accumulating 22 citations, critically examines the growing but unproven trend of using minimally invasive surgery for advanced ovarian cancer, highlighting the urgent need for rigorous randomized clinical trials to validate its safety and effectiveness. By challenging the field to demand high-quality evidence before adopting new techniques, Dr. Horowitz demonstrates a commitment to both innovation and patient safety. His work continues to influence surgical decision-making and trial design, making him a respected voice in the ongoing evolution of gynecologic oncology.